Telix Pharmaceuticals files $50M Underwritten Initial Public Offering

MELBOURNE (Australia) – 16 October 2017. Telix Pharmaceuticals files $50 million underwritten Initial Public Offering.

Telix Pharmaceuticals is pleased to announce it has filed a $50 million Underwritten Initial Public Offering.

To view our prospectus, click here.